toxicology for the anaesthetist
DESCRIPTION
Toxicology for the Anaesthetist. The concepts of management of drug overdose in general Specific drugs ( Paracetamol , salicylates , opiates, TCA, digoxin , beta blockers, Organophosphates, Cyanide/ Nitroprusside , Methaemaglobinaemia , Carbon monoxide). The Principles of management. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/1.jpg)
Toxicology for the Anaesthetist
![Page 2: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/2.jpg)
• The concepts of management of drug overdose in general
• Specific drugs(Paracetamol, salicylates, opiates, TCA, digoxin,
beta blockers, Organophosphates, Cyanide/Nitroprusside, Methaemaglobinaemia, Carbon monoxide)
![Page 3: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/3.jpg)
The Principles of management
• 1) Exposure PhaseIrrigation, dilution, Adsorbants
![Page 4: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/4.jpg)
2) Toxokinetic phase
• Accelerated passage: Emesis, Gastric Lavage, Laxatives• Enhanced elimination: Manipulation of urinary pH, forced diuresis,
Dialysis, Haemofiltration
SLIME (Salicylate, lithium, Isopropanol, Mg laxatives, ethylene glycol)
![Page 5: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/5.jpg)
3) Toxodynamic phase – Antidote/supportive care
• Neutralisation/ complexation (Digoxin Fab)• Increased biotransformation (NAC)• Decreased biotransformation to toxic
metabolites (Ethanol vs ethylene glycol)• Elevated threshold of toxicity due to
competitive antagonism (Amyl Nitrate)
![Page 6: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/6.jpg)
Paracetamol• Toxic metabolite: N-acetyl-p-benzoquinoneimine depletes
the liver's natural antioxidant glutathione and directly damages cells in the liver – centrilobular necrosis
• Single ingestion >12g (200mg/kg) vs staggered• Time since ingestion (4hrs) ?Activated Charcoal (<1hr)• High Risk (Etoh, Induced liver enzymes, fasting/anorexia
nervosa, INH) Acute toxicity rare in children• Guidelines to managment readily available• N-Acetylcysteine (Precursor for glutathione production)
![Page 7: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/7.jpg)
![Page 8: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/8.jpg)
Problems with NAC
• Oral NAC + activated charcoal and the taste• The most common adverse effect to acetylcysteine
treatment is an anaphylactoid reaction, usually manifested by rash, wheeze, or mild hypotension
• More common with IV acetylcysteine (4 to 23%)• Severe life-threatening reactions are rare - may occur in
predisposed individuals - eg asthma• If a anaphylactoid reaction occurs acetylcysteine is
temporarily halted or slowed and antihistamines and other supportive care is administered
![Page 9: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/9.jpg)
Salicylates• Acute overdose has a mortality rate of 2%. Chronic overdose
is more commonly lethal - 25%. Children are at greater risk• Mild :nausea and vomiting, abdominal pain, lethargy,
tinnitus, and dizziness• Severe: hyperthermia, tachypnea, respiratory alkalosis,
metabolic acidosis, hypokalemia, hypoglycemia, hallucinations, confusion, seizure, cerebral edema, and coma
• Spectrophotometric plasma salicylate levels generally range from 30-100 mg/L (3-10 mg/dL) after usual therapeutic doses, 50-300 mg/L in patients taking high doses and 700-1400 mg/L following acute overdose
![Page 10: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/10.jpg)
![Page 11: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/11.jpg)
Treatment options• Activated Charcoal: Additional charcoal if serum salicylate levels are
increasing • D5W to keep a urinary output between 2 - 3 ml/kg/hr• Alkalinization of the urine: (salicylate level greater than 35 mg/dl 6
hours after ingestion – aim urine pH 7.5 - 8.0)) Sodium bicarbonate administered regardless of the serum pH as it enhances elimination of aspirin in the urine
• Haemodialysis: Acute ingestions (100 mg/dL), Chronic ingestions(40 mg/dL),or significant neurotoxicity (agitation, coma, convulsions), renal failure, pulmonary edema, or cardiovascular instability.
Advantage of restoring electrolyte and acid-base abnormalities while removing salicylate
![Page 12: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/12.jpg)
TCA’s
• Narrow TI• ANS,CNS,CVS• 4 major pharmacological effects: • Anticholinergic effects• Excessive blockade of norepinephrine reuptake at the
postganglionic synapse• Direct alpha adrenergic blockade• Blockade of sodium membrane channels with slowing of
membrane depolarization -quinidine like effects on the myocardium
![Page 13: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/13.jpg)
![Page 14: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/14.jpg)
Management• Assess and treat ABCs as appropriate• ECG - QRS>0.10 seconds• Gastric lavage only if within one hour and life-threatening• Activated charcoal if within one hour • Give sodium bicarbonate (50 ml of 8.4%) if
– pH <7.1, QRS >0.10 sec, arrhythmias, ↓ BP • Arrhythmias
– Avoid antiarrhythmics (phenytoin, lignocaine)– Correct hypoxia, ↓BP, acidosis, hypokalemia
• Hypotension – IV fluids, inotropes• Cardiac arrest – prolonged resuscitation successful• Monitoring – minimum 6-12 hours without sign of toxicity in ICU• Highly protein bound with a large volume of distribution; therefore
hemodialysis, hemoperfusion or other techniques are unlikely to be of any significant benefit
![Page 15: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/15.jpg)
• Indications for RSI: TCA overdose delays gastric emptying and may cause vomiting, increasing• aspiration risk, particularly in patients with reduced level of consciousness. A low threshold for early• intubation should be adopted and the need should be continually reassessed. It is imperative to• ensure the availability of adequate expertise during rapid sequence induction.• Gastric decontamination: Activated charcoal may be considered for use within 1 hour of TCA• ingestion but only in patients with an intact or secured airway. The potential risk of aspiration should• be strongly considered before use. Gastric lavage may be considered for potentially lifethreatening• TCA overdoses only when it can be delivered within 1 hour of ingestion and the airway• is protected.• Hypotension: TCA overdose causes hypotension by reducing preload and afterload as well as• direct effects on the myocardium. Optimising the preload may reverse hypotension. This may be• achieved by head-down tilt and bolus of intravenous fluid. Sodium bicarbonate may reverse• hypotension even in the absence of acidosis and is indicated if hypotension is persistent. If• hypotension still persists, vasopressors/inotropes should be used. There is some evidence that• epinephrine may be preferable to norepinephrine in this situation.• Arrhythmias: Administration of sodium bicarbonate, even in the patient without acidosis, may• reverse TCA-induced arrhythmias. If arrhythmias are persistent, magnesium sulphate may be given,• although there is limited available evidence for its efficacy.• ECG abnormalities: QRS prolongation (>0.10s) and right axis deviation are associated with• increased risk of cardiac arrhythmias. The use of sodium bicarbonate should be strongly considered• in this situation.• Sodium bicarbonate: For life-threatening toxicity use 50-100ml 8.4% sodium bicarbonate. The dose• can be repeated with blood gas monitoring to a target pH of 7.45-7.55. For more stable patients• 500ml 1.26% sodium bicarbonate carries less risk of skin necrosis in the event of extravasation.• Seizures: Prolonged seizures should be treated initially with benzodiazepines. Phenytoin should be• avoided because of a possible interaction with TCA’s. If there is no response to benzodiazepines• RSI should be considered.• ECG monitoring is essential for all patients at moderate/high risk. Serial 12-lead ECG recording is• recommended in all patients to monitor for changes in QRS duration.
![Page 16: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/16.jpg)
Digoxin
• Very narrow therapeutic window• Nonspecific: fatigue, blurred vision, change in color
vision (eg. "yellow" vision"), anorexia, nausea, vomiting, diarrhea, abdominal pain, headache, dizziness, confusion, delirium
• Therapeutic level for digoxin is 0.5-0.8 ng/mL• Low serum potassium increases the risk of digoxin
toxicity and cardiac dysrhythmias• Classic arrhythmia is a paroxysmal atrial tachycardia
with block.
![Page 17: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/17.jpg)
![Page 18: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/18.jpg)
Treatment
• Supportive measures – Hypokalaemia exacerbates digoxin toxicity
• The primary treatment of digoxin toxicity is digoxin immune Fab
• Other treatment: magnesium, phenytoin, and lidocaine
• Atropine can also used in cases of bradyarrhythmias
![Page 19: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/19.jpg)
Other drugs and their antidotes
Opiates• Naloxone
Benzodiazepines• Flumazenil• Not to be used in mixed
overdoses
![Page 20: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/20.jpg)
Beta blockers• If the patient is hypotensive, administer 20 mL/kg of isotonic intravenous
fluids and place the patient in the Trendelenburg position. If the patient does not respond to these measures, the following interventions may be considered:
• Inotropes and chronotropes• Glucagon (Diagnostic and DOC)• Gastric decontamination• Benzodiazepines (in patients with seizures)• Hemodialysis (Atenolol, low protein binding)• Cardiac pacing/cardiopulmonary resuscitation• Insulin (effects on contractility)• Intravenous fat emulsion (Propanolol, verapamil, other lipid soluble drugs)
![Page 21: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/21.jpg)
Local Anaesthetics
• Myonecrosis• Nerve injury/TNS• Neurotoxicity• Cardiotoxicity – Intralipid• Methaemaglobinaemia (Prilocaine/EMLA,
Benzocaine)
![Page 22: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/22.jpg)
Cyanide/SNP
• Potential adverse effects on organ systems• Toxicity – Plasma CN > 8µg/ml• Increased risk (tachyphylaxis, hypothermia,
renal failure, hepatic failure, B12 deficiency)• Uncouples oxidative phosphorylation• Met Acidosis, increased venous sats,
arrhythmias, tachyphylaxis
![Page 23: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/23.jpg)
![Page 24: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/24.jpg)
Electron transfer from
Fe2+(ie SNP + OxyHb)
Red blood Cells
SNP
5CN-
MetHbN=O
![Page 25: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/25.jpg)
• N=O activates guanylate cyclasecGMP effects free intracellular Ca2+Smooth muscle relaxation• Methaemoglobin (Fe3+)• CN- + Cytochrome oxidase = Cyanide Toxicity
![Page 26: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/26.jpg)
Handling the CN-1.Dicobalt edetateChelation2.Nitrites (Sodium/Amyl)Converts OxyHb to MetHb – higher affinity for CN- than
cytochrome oxidaseProduces CyanmetHb3.Sodium ThiosulphateRelies on Rhodanase and VitB12 to produce Thiocyanate (100x less
toxic than CN-)4.Vitamin B12No value in the acute setting
![Page 27: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/27.jpg)
Assessment and treatment• Signs of cyanide toxicityCentral nervous system dysfunction: mental status change, seizure, comaCardiovascular instability: tachyphylaxis (hypertension); electrocardiogram
changes (arrhythmias, ST segmentchanges)Increasing metabolic acidosis: increasing base deficit; plasma lactate > 10• Treatment of suspected cyanide toxicity• Stop infusion of SNP• 100% oxygen (despite normal 0, saturation)• Mechanical ventilation as indicated• Correction of metabolic acidosis with NaHCO3,• 3% sodium nitrite 4-6 mg/kg slow intravenously (IV)• Sodium thiosulfate 150-200 mg/kg IV over 15 min• Consider hydroxycobalamin (vitamin B12) 25 mg/h
![Page 28: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/28.jpg)
Methaemoglobinaemia
![Page 29: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/29.jpg)
• Methemoglobin is an oxidized form of hemoglobin
ie Result of OXIDATIVE STRESS• Increased affinity for oxygen, resulting in a
reduced ability to release oxygen to tissues.• The oxygen–hemoglobin dissociation curve is
shifted to the left• Tissue hypoxia
![Page 30: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/30.jpg)
• Congenital: (Enzyme deficiency)Diaphorase I (NADH methaemoglobin reductase)Pyruvate KinaseG-6-PD• Acquired
![Page 31: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/31.jpg)
• Gives blood a bluish or chocolate-brown color.• Spontaneous formation of methemoglobin is
normally reduced (via electron donation) by protective enzyme systems
1) NADH methemoglobin reductase/ Cytochrome-b5 reductase (major pathway)
2) NADPH methemoglobin reductase (minor pathway) The NADPH is generated via the hexose monophosphate shunt
3) To a lesser extent the ascorbic acid and glutathione enzyme systems
![Page 32: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/32.jpg)
• Methylene blue provides an artificial electron acceptor for NADPH methemoglobin reductase
• Diaphorase II normally contributes only a small percentage of the red blood cells reducing capacity but is pharmacologically activated by exogenous cofactors. Methylene blue allows the enzyme to function at 5x normal levels
![Page 33: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/33.jpg)
![Page 34: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/34.jpg)
Organophosphate Poisoning
SLUDGEM • Salivation• Lacrimation• Urination• Defecation• Gastrointestinal motility• Emesis• Miosis
![Page 35: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/35.jpg)
• Nicotinic expression at the neuromuscular junctionMuscle weakness, fatigue, muscle cramps, fasciculation, and
paralysis• Autonomic ganglia - overstimulation of nicotinic expression in
the sympathetic systemHypertension, increased heartbeat and blood pressure,
hypertension, and hypoglycemia• CNS - accumulation of AchAnxiety, headache, convulsions, ataxia, depression of respiration
and circulation, tremor, general weakness, and potentially coma
• Muscarinic overstimulationVisual disturbances, tightness in chest, wheezing due to
bronchoconstriction, increased bronchial secretions, increased salivation, lacrimation, sweating, peristalsis, and urination
![Page 36: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/36.jpg)
Treatment
• Supportive• Atropine – Glycopyrolate• Irreversible vs reversibleObidoxime, pralidoxime
![Page 37: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/37.jpg)
Carbon Monoxide
• Naturally produced by the action of haemoxygenase 1 and 2 on the haem from haemoglobin breakdown
1. Reduces O2 carrying capacity (230x affinity of O2 for Hb)
2. Adverse effect on mitochondrial cytochrome oxidase, binds to myoglobin and causes brain lipid peroxidation
![Page 38: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/38.jpg)
Concentration Symptoms
35 ppm (0.0035%) Headache and dizziness within six to eight hours of constant exposure
100 ppm (0.01%) Slight headache in two to three hours
200 ppm (0.02%) Slight headache within two to three hours; loss of judgment
400 ppm (0.04%) Frontal headache within one to two hours
800 ppm (0.08%) Dizziness, nausea, and convulsions within 45 min; insensible within 2 hours
1,600 ppm (0.16%) Headache, tachycardia, dizziness, and nausea within 20 min; death in less than 2 hours
3,200 ppm (0.32%) Headache, dizziness and nausea in five to ten minutes. Death within 30 minutes.
6,400 ppm (0.64%)Headache and dizziness in one to two minutes. Convulsions, respiratory arrest, and death in less than 20 minutes.
12,800 ppm (1.28%) Unconsciousness after 2-3 breaths. Death in less than three minutes.
![Page 39: Toxicology for the Anaesthetist](https://reader036.vdocuments.mx/reader036/viewer/2022062302/568164ae550346895dd6b9a6/html5/thumbnails/39.jpg)
A few points
• Patients don’t arrive with labelsConsider the toxidromes• Illicit drug use is more common than we
realise• Don’t forget nutriceuticals and their effects• There are helpful resources on the internet
and poison centres open 24 hrs a day• SAMF is a reasonable reference if you’re still
lost